Asenapine

Molecular mass: 285.77 g/mol  PubChem compound: 163091

Therapeutic indications

Asenapine is indicated for:

Moderate to severe manic episodes associated with bipolar I disorder

Population group: only adults (18 years old or older)

Asenapine is indicated for the treatment of moderate to severe manic episodes associated with bipolar I disorder in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Asenapine is contraindicated in the following cases:

Lactation

Lactation

Elderly patients with dementia-related psychosis

Population group: only elderly (65 years old or older)

Senile dementia with psychosis

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2017: SAPHRIS Tablet
Summary of Product Characteristics (SPC) 2022: SYCREST Sublingual tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈